BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34468763)

  • 1. Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis.
    Fabri RL; Freitas JCO; Lemos ASO; Campos LM; Diniz IOM; Pinto NCC; Silva TP; Palazzi C; Marchesini P; Monteiro C; Barbosa AF; Carvalho MG; Chedier LM; Araújo MGF; Apolônio ACM; Rocha VN; Melo RCN; Pinto PF
    Med Mycol; 2021 Dec; 59(12):1210-1224. PubMed ID: 34468763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
    Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
    Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
    Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
    Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiofilm potential of Annona muricata L. ethanolic extract against multi-drug resistant Candida albicans.
    Campos LM; Silva TP; de Oliveira Lemos AS; Mendonça Diniz IO; Palazzi C; Novaes da Rocha V; de Freitas Araújo MG; Melo RCN; Fabri RL
    J Ethnopharmacol; 2023 Oct; 315():116682. PubMed ID: 37263318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
    Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro outcomes of quercetin on Candida albicans planktonic and biofilm cells and in vivo effects on vulvovaginal candidiasis. Evidences of its mechanisms of action.
    Tan Y; Lin Q; Yao J; Zhang G; Peng X; Tian J
    Phytomedicine; 2023 Jun; 114():154800. PubMed ID: 37043980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
    de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
    J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress induced by piperine leads to apoptosis in Candida albicans.
    Thakre A; Jadhav V; Kazi R; Shelar A; Patil R; Kharat K; Zore G; Karuppayil SM
    Med Mycol; 2021 Apr; 59(4):366-378. PubMed ID: 32658959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kovács R; Holzknecht J; Hargitai Z; Papp C; Farkas A; Borics A; Tóth L; Váradi G; Tóth GK; Kovács I; Dubrac S; Majoros L; Marx F; Galgóczy L
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
    Mushi MF; Olum R; Bongomin F
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis.
    Andrade JT; Fantini de Figueiredo G; Cruz LF; Eliza de Morais S; Souza CDF; Pinto FCH; Ferreira JMS; Araújo MGF
    Rev Iberoam Micol; 2019; 36(4):192-199. PubMed ID: 31757595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilms and vulvovaginal candidiasis.
    Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
    Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
    Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
    PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.